Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Modified Cangma Decoction is a traditional Chinese medicine (TCM) herbal formula, which is a variation of the classic "Cangma Decoction." Like many TCM decoctions, it consists of multiple herbs combined according to TCM principles and may be adjusted ("modified") by practitioners for specific clinical indications. The original Cangma Decoction is traditionally used for neurological conditions such as stroke or sequelae of cerebrovascular disease. The mechanism of action typically involves promoting blood circulation, resolving phlegm, and supporting neurological recovery through multi-target effects on inflammation, oxidative stress, and neuroprotection. Modified versions may include additional herbs or altered dosages to enhance efficacy or tailor treatment to individual patient needs. There are no standardized formulations; composition varies by practitioner and study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on modified Cangma Decoction.